MELOGLIPTIN
Melogliptin Phase III A DP-IV inhibitor potentially for treatment of type II diabetes. EMD-675992; GRC-8200 CAS No. 868771-57-7 4-fluoro-1-[2-[[(1R,3S)-3-(1,2,4-triazol-1-ylmethyl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile 4(S)-Fluoro-1-[2-[(1R,3S)-3-(1H-1,2,4-triazol-1-ylmethyl)cyclopentylamino]acetyl]pyrrolidine-2(S)-carbonitrile Note………The views expressed are my personal and in no-way…
View On WordPress














